Posted by Michael Wonder on 09 Jan 2026
GSK’s Shingrix (recombinant zoster vaccine) pre-filled syringe presentation approved by the European Commission
7 January 2026 - New presentation will begin rolling out across EU countries in 2026.
GSK today announced the European Commission’s approval of Shingrix (GSK’s recombinant zoster vaccine) in a pre-filled syringe.
